Carbon Quantum Dot
Carbon Quantum Dots (CQDs), also referred to as carbon dots or C-dots, are a family of nanoscale carbon-based particles typically under 10 nanometres in diameter that exhibit strong fluorescence and quantum confinement effects. They were first discovered serendipitously in 2004 during the purification of single-walled Carbon Nanotubes via electrophoresis, when researchers noticed unexpectedly luminescent carbonaceous fractions. Unlike conventional semiconductor Quantum Dots based on cadmium, lead, or indium — materials associated with significant toxicity — CQDs are derived from carbon, the foundational element of all biological life. This gives them a fundamentally different toxicological and regulatory profile, and has driven enormous interest in their potential biomedical, sensing, and optoelectronic applications. Some independent researchers have also raised questions about the presence of carbon-based nanoparticulate structures, potentially including CQDs or closely related derivatives, in injectable pharmaceutical products including COVID Vaccines.
Structure and Properties
CQDs consist of a core-shell architecture that sets them apart from both bulk carbon allotropes and larger nanostructures:
Core Structure
The interior of a CQD typically consists of a graphitic or amorphous carbon lattice — essentially a disordered arrangement of sp² and sp³ hybridised carbon atoms. Some CQDs exhibit a crystalline graphitic core with lattice spacings consistent with graphene-like layers, while others are predominantly amorphous. This internal structure contributes to the quantum confinement of electrons that underpins their optical behaviour.
Surface Functional Groups
The surface of CQDs is rich in oxygen-containing functional groups including:
- Hydroxyl groups (–OH)
- Carboxyl groups (–COOH)
- Epoxide groups (C–O–C)
- Amino groups (–NH₂) in nitrogen-doped variants
These groups make CQDs highly water-soluble and chemically reactive — properties essential for biological applications. They also allow surface functionalisation with drugs, targeting ligands, or other molecules.
Photoluminescence
The fluorescence of CQDs is one of their most striking features. The precise mechanism remains an active area of scientific debate, but is generally attributed to a combination of:
- Quantum confinement effects — restriction of electron movement in particles smaller than the Bohr exciton radius
- Surface state emission — fluorescence arising from defect sites and functional groups on the particle surface
- Molecular fluorophores — in some synthesis routes, small fluorescent organic molecules embedded in or attached to the carbon core
A key property is excitation-dependent emission: as the excitation wavelength changes, the emission peak shifts correspondingly. A sample of CQDs illuminated with UV light may glow blue, while the same sample illuminated with visible light may emit green or yellow. This property is useful for multicolour bioimaging but also complicates standardisation.
Quantum yields — the efficiency of fluorescence conversion — vary widely from less than 1% to over 80% depending on synthesis method, surface passivation, and doping. Nitrogen-doped CQDs (N-CQDs) consistently achieve higher quantum yields than undoped variants.
Synthesis Routes
CQDs can be produced through two broad categories of approach:
Top-Down Methods
These methods begin with larger carbon materials and break them down to the nanoscale:
- Laser ablation — a pulsed laser irradiates a graphite or carbon target in liquid medium, generating nanoscale carbon fragments. This was the original discovery route.
- Arc discharge — high-voltage electrical discharge between carbon electrodes in liquid or gas produces carbonaceous nanomaterials including CQDs.
- Chemical oxidation — treatment of carbon black, graphite, or carbon nanotubes with strong acids (nitric acid, sulphuric acid) cleaves the material into nanoscale fragments while simultaneously introducing surface oxygen groups.
- Electrochemical oxidation — electrochemical exfoliation of graphite electrodes in aqueous electrolyte.
Bottom-Up Methods
These approaches assemble CQDs from small molecular precursors:
- Hydrothermal synthesis — organic precursors dissolved in water are heated under pressure in a sealed autoclave, typically at 150–250°C for several hours. This induces carbonisation and self-assembly of the carbon framework.
- Microwave-assisted synthesis — similar precursors are rapidly heated in a microwave reactor, producing CQDs in minutes rather than hours.
- Pyrolysis — thermal decomposition of organic precursors at elevated temperatures.
One of the most notable features of bottom-up synthesis is the extreme simplicity of precursors that can be used. CQDs have been successfully synthesised from:
- Citric acid and urea
- Glucose and amino acids
- Orange juice, lemon juice, and other fruit extracts
- Coffee grounds, soy milk, grass, and various forms of food waste
- Hair and other biological materials
This accessibility has made CQDs attractive for low-cost, scalable production, and has driven significant research in developing countries.
Biomedical Applications
The low cytotoxicity, water solubility, and tunable fluorescence of CQDs have made them candidates for numerous biomedical applications:
Bioimaging
CQDs can be taken up by living cells and imaged using conventional fluorescence microscopy. Their brightness, photostability (resistance to photobleaching), and emission tunability make them competitive with organic fluorescent dyes. Because they lack the heavy metal content of traditional Quantum Dots, their cytotoxicity profile is generally superior — though this does not mean they are entirely inert, and cell-type-specific effects have been reported.
Drug Delivery
The richly functionalised surface of CQDs allows attachment of pharmaceutical agents. CQDs can act as nanocarriers — transporting drugs through the bloodstream, potentially crossing biological barriers, and releasing their payload in response to environmental triggers such as pH change or light irradiation. This is of particular interest for targeted cancer therapy.
Photodynamic Therapy
Under light irradiation, certain CQDs generate reactive oxygen species (ROS) capable of destroying cancer cells or pathogens. This photosensitising behaviour has led to investigations of CQDs as photodynamic therapy (PDT) agents.
Biosensing
CQDs are sensitive to their chemical environment — their fluorescence can be quenched or enhanced by specific molecules. This makes them useful as Biosensor elements for detecting metals, pH, glucose, proteins, nucleic acids, and pathogens. CQD-based biosensors have been demonstrated for detection of lead ions, mercury, dopamine, and various disease biomarkers.
Antimicrobial Applications
Several studies have reported antimicrobial activity of CQDs against bacteria and viruses. The mechanism may involve membrane disruption, ROS generation, or direct interference with microbial replication machinery. CQD-based antimicrobial coatings and wound dressings have been proposed.
CQDs in Vaccines and Injectable Products
Some independent researchers and analysts have raised concerns about the presence of carbon-based nanoparticulate structures in COVID Vaccines and other injectable products. Groups including La Quinta Columna, led by Ricardo Delgado and Dr. José Luis Sevillano, and the analytical platform Corona2Inspect, have published electron microscopy images and spectroscopic data they claim show graphene-family nanostructures — potentially including graphene quantum dots and CQDs — in vaccine vials from multiple manufacturers.
According to these researchers, structures detected via transmission electron microscopy (TEM) and Raman spectroscopy in COVID-19 vaccine samples display optical and morphological characteristics consistent with graphene-derived or carbon quantum dot material. They suggest these structures were not disclosed in official ingredient lists and may have biological signalling or electromagnetic interaction properties relevant to concerns raised in the Intra-Body Nano Network literature.
It should be noted that mainstream regulatory bodies including the EMA and FDA have not acknowledged undisclosed carbon nanoparticulates in approved vaccines. The researchers' findings remain contested and have not been replicated in peer-reviewed institutional settings. However, some independent scientists have called for more rigorous and open independent analysis of vaccine contents. These claims intersect with broader discussions documented in Nanoparticles in Vaccines and Graphene in Vaccines.
Some researchers draw attention to the fact that the unique optical properties of CQDs — particularly excitation-dependent fluorescence — could theoretically serve as covert detection or tracking markers, a possibility that remains speculative but is discussed in the context of Nanotechnology governance debates.
Graphene Relationship
CQDs exist within a broader family of carbon nanomaterials, and their boundaries with related structures are not always sharp:
- Graphene — a two-dimensional single-atom-thick carbon sheet. CQDs can be considered zero-dimensional fragments of graphene.
- Graphene Quantum Dots (GQDs) — a specific subtype of CQD in which the carbon core is crystalline and graphitic, with well-defined graphene lattice structure. GQDs exhibit stronger quantum confinement and sharper emission spectra than amorphous CQDs. Some researchers use the terms interchangeably, which contributes to confusion in the literature.
- Graphene Oxide — graphene functionalised with oxygen groups; chemically related to oxidised CQDs and similarly detectable by Raman spectroscopy.
- Carbon Nanotubes — one-dimensional rolled graphene sheets; a distinct morphology but part of the same sp²-carbon family. CQDs were historically first isolated as a byproduct of carbon nanotube purification.
The relationship between these materials matters practically: Raman spectroscopy, which is the primary tool used to identify graphene and graphene oxide in vaccine samples by independent researchers, would not necessarily distinguish GQDs from Graphene Oxide or other graphene-family materials without additional characterisation.
Regulatory and Toxicological Status
CQDs are generally regarded as having a more favourable toxicological profile than heavy-metal-based quantum dots such as cadmium selenide (CdSe) or lead sulphide (PbS), which are acutely toxic and environmentally persistent. However, the regulatory and toxicological status of CQDs remains genuinely unsettled:
- In vitro studies (cell culture) generally show low toxicity at typical imaging concentrations, though this varies by CQD type, surface chemistry, and cell line.
- In vivo studies in animals suggest that CQDs can distribute to multiple organs including liver, spleen, and kidneys, and are gradually excreted — but long-term fate and chronic exposure data remain limited.
- Surface chemistry matters enormously — the functional groups on CQD surfaces, not just the carbon core, determine biological interactions. Amino-functionalised CQDs, for example, tend to be more cytotoxic than carboxyl-functionalised variants.
- Regulatory frameworks for nanomaterials generally are still evolving. CQDs do not yet have dedicated regulatory classification in most jurisdictions. They may fall under general nanomaterial guidance from the EMA, FDA, or EPA depending on application.
The field of Nanotoxicology has repeatedly demonstrated that nanoscale particles can exhibit biological effects absent in bulk equivalents of the same material — a principle that cautions against assuming that carbon-based nanoparticles are automatically safe simply because carbon itself is biocompatible.
Independent researchers have called for mandatory disclosure and safety testing of any nanoparticulate content in pharmaceutical products, arguing that current regulatory frameworks are insufficient to assess nanoscale materials that may interact with cellular machinery, bioelectric fields, or electromagnetic signals in ways not yet fully characterised.
